Clinical Trial Update: Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck [EARLY_Phase 1]

View source ↗

Summary

A randomized pre-surgical window-of-opportunity trial of TTI-101 in HPV-negative stage II-IV resectable head and neck squamous cell carcinoma has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• TTI-101

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Squamous Cell Carcinoma of Head and Neck | EARLY_Phase 1 | Status: WITHDRAWN